Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 454,497
▲ 65% vs 2024
Profit
Growing€ 313,819
▲ 68% vs 2024
Debts
High€ 1.7 million
▼ 10% vs 2024
CARDIAC RESEARCH INSTITUTE from Aalst, company number BE0629850791, closed financial year 2025 with a result of € 313,819 after tax. For that financial year CARDIAC RESEARCH INSTITUTE recorded a gross margin of € 454,497 and equity of € 206,225. Compared with financial year 2024, the result moved from € 186,300 to € 313,819. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
What happened at CARDIAC RESEARCH INSTITUTE?
What happened at CARDIAC RESEARCH INSTITUTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dr. T. De Potter bv stepped down as director. NBB
- Dr. W. Heggermont, Cardiologie bv stepped down as director. NBB
- Dicentra bv stepped down as director. NBB
- Dr. E. Wyffels bv stepped down as director. NBB
- Dokter Peter Peytchev bv stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 313,819 (▲ 68% vs 2024). Source: NBB ↗
- Dr. T. De Potter bv became a director. NBB
- Dr. W. Heggermont, Cardiologie bv became a director. NBB
In short
From € 129,520 profit in 2021 to € 313,819 profit in 2025.
Paid € 306,183 in corporate taxes since 2021.
Best year ever: 2025, with € 313,819 profit.
Paid out € 865,110 in dividends to the owners in total.
A new publication or filing at CARDIAC RESEARCH INSTITUTE? We notify you, reason included.
Follow CARDIAC RESEARCH INSTITUTENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Tom De Potter
since 2024 · until 2029
Dr. W. Heggermont, Cardiologie bv
Director · represented by Ward Heggermont
since 2024 · until 2029
Director · represented by Jozef Bartúnek
since 2024 · until 2029
Director · represented by Eric Wyffels
since 2024 · until 2029
Director · represented by Peter Peytchev
since 2024 · until 2029
Establishments
Establishment units
Physical locations of this company
Moorselbaan 164
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
Onze-Lieve-Vrouwziekenhuis
€ 0 revenue · 2025
Vakantiedialyse
Cardiovascular Research Center Aalst
€ 173,775 gross margin · 2025
NEUROCHIRURGIE
OLV RESEARCH UNIT
€ -57,102 gross margin · 2022
+19 more
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0629.850.791
- VAT number
- BE 0629.850.791
- Registered office
- Moorselbaan 164, 9300 Aalst
- Names & denominations
- CARDIAC RESEARCH INSTITUTE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 May 2015
- Peppol
- Active · Active since 9 Feb 2026
- Contact
- hartvoorresearchaalst.be
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied